Optimized Nutrition in Mitochondrial Diseases Correlates with Improved Muscle Fatigue, Strength, and Quality of Life: You Are What You Eat, or Are You?

Saneto RP. Mitochondrial diseases: expanding the diagnosis in the era of genetic testing. J Transl Genet Genom. 2020;4:384–428. Emmanuele V, Ganesh J, Vladutiu G, Haas R, Kerr D, Saneto RP, et al. Time to harmonize mitochondrial syndrome nomenclature and classification: a consensus from the North American Mitochondrial Disease Consortium, (NAMDC). Mol Genet and Metab. 2022;136:125–31. Russell OM, Gorman GS, Lightolers RN, Turnbull DM. Mitochondrial diseases: hope for the future. Cell. 2020;181:168–88. Karaa A, Klopstock T. Clinical trials in mitochondrial diseases. Handb Clin Neurol. 2023;194:229–50. DiVito D, Wellik A, Burfield J, Peterson, J, Flickinger J, Tindall A, et al. Clinical nutrition in mitochondrial disease correlates to improved muscle fatigue, strength, and quality of life. Neurotherapeutics. 2023 (this issue). Liesa M, Shirihai OS. Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure. Cell Metab. 2013;2(17):491–506. Sturm G, Karan KR, Monzel AS, Santhanam B, Taivassalo T, Bris C, et al. OxPhos defects cause hypermetabolism and reduce lifespan in cells and in patients with mitochondrial diseases. Commun Biol. 2023;6:22. Kyriazis ID, Vassi E, Alvanou M, Angelakis C, Skaperda Z, Tekos F, et al. The impact of diet upon mitochondrial physiology (Review). Int J Mol Med. 2022;50:135. Karaa A, Kriger J, Grier J, Holbert A, Thompson JL, Parikh S, et al. Mitochondrial disease patients’ perception of dietary supplements’ use. Mol Genet Metab. 2016;119:100–8. Zolkipli-Cunningham Z, Xiaxo R, Stoddan A, McCormick EM, Holberts A, Burrill N, et al. Mitochondrial disease patient motivations and barriers to participate in clinical trials. PLoS ONE. 2018;13:e0197513. Madsen KL, Buch AE, Cohen BH, Falk MJ, Goldsberry A, Goldstein A, et al. Safety and efficacy of omaveloxolone in patients with mitochondrial myopathy: MOTOR trial. Neurology. 2020;18(94):e687–98. Karaa A, Haas R, Goldstein A, Vockley J, Cohen BH. A randomized crossover trial of elamipretide in adults with primary mitochondrial myopathy. J Cachexia Sarcopenia Muscle. 2020;11(4):909–18. Karaa A, Haas R, Goldstein A, Vockley J, Weaver WD, Cohen BH. Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy. Neurology. 2018;90:e1212–21. Erratum in: Neurology. 2018;90:669. Erratum in: Neurology. 2018 Nov 20; 91:986.